58
Growth Score
pts
Heat Score
-27 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
322874
Nospharma develops treatments for rare genetic neurological disorders, focusing on innovative therapeutic approaches.
- Anmol Nagpal: CEO & Co-Founder
- Derek Bowie: Co-Founder & CSO
About the Company
Nospharma is a biotechnology company focused on the development of innovative treatments for rare genetic neurological disorders. Operating in the preclinical and clinical stages, the company is dedicated to advancing therapeutic solutions aimed at addressing the challenges of conditions such as SynGAP1-related disorders. Nospharma employs a unique
approach by utilizing a combination of multiple small-molecules and peptides to target the key pathologies of these rare genetic conditions. With a commitment to innovation and a specialized focus on neurological health, Nospharma strives to improve the lives of patients facing these complex disorders.
